Results 21 to 30 of about 147,721 (313)

Association of Aortic Arch Calcification on Chest X-ray with Procedural Thromboembolism after Mechanical Thrombectomy for Acute Ischemic Stroke

open access: yesMedicina, 2021
Background and Objective: Procedural thromboembolism after a mechanical thrombectomy (MT) for an acute ischemic stroke (AIS) has rarely been studied. It may occur from the artery-to-artery embolization of atherosclerotic plaque in the aortic arch.
Hoon Gi Kim   +7 more
doaj   +1 more source

Venous thromboembolism in patients with gout and the impact of hospital admission, disease duration and urate-lowering therapy. [PDF]

open access: yes, 2019
BACKGROUND: Systemic inflammatory diseases have been associated with increased risk of venous thromboembolism. We aimed to quantify the risk of venous thromboembolism in patients with gout, the most common inflammatory arthritis, and to assess how ...
Roddy, E   +3 more
core   +1 more source

Edoxaban: an update on the new oral direct factor Xa inhibitor. [PDF]

open access: yes, 2014
Edoxaban is a once-daily oral anticoagulant that rapidly and selectively inhibits factor Xa in a concentration-dependent manner. This review describes the extensive clinical development program of edoxaban, including phase III studies in patients with ...
Camm, AJ   +3 more
core   +1 more source

Acute Unilateral Renal Infarction in the Setting of an Inherited Thrombophilia and Atrial Septal Defect

open access: yesCase Reports in Hematology, 2017
We present a case of renal infarction in a 43-year-old female with history of stroke at age 14. She was found to be heterozygous for the prothrombin G20210A gene mutation. Loop monitoring revealed no atrial fibrillation. Transthoracic and transesophageal
Siavash Piran, Sam Schulman
doaj   +1 more source

Apixaban for the prevention of thromboembolism in adults after elective hip or knee replacement surgery, and in symptomatic venous thromboembolism [PDF]

open access: yes, 2012
The anticoagulant effect of apixaban is due to direct inhibition of FXa in the coagulation cascade. The main advantages apixaban has over the current anti-coagulant drugs is that it is active after oral administration, and its coagulation effect does not
Doggrell, Sheila
core   +1 more source

The Massive Online Needs Assessment (MONA) to inform the development of an emergency haematology educational blog series

open access: yesPerspectives on Medical Education, 2018
Background Online educational resources are criticized as being teacher-centred, failing to address learner’s needs. Needs assessments are an important precursor to inform curriculum development, but these are often overlooked or skipped by developers of
Teresa M. Chan   +8 more
doaj   +1 more source

Thromboembolic complications in COVID-19 disease, a brief update

open access: yesВестник анестезиологии и реаниматологии, 2021
The role of coagulopathy in severe novel coronavirus infection remains to be clarified. Coagulopathy mechanisms can be summarised in two main pathways: inflammation-related and specific-virus related pathways.
А. Lavrentieva, S. Tsotsolis
doaj   +1 more source

Cancer and thrombosis: Managing the risks and approaches to thromboprophylaxis [PDF]

open access: yes, 2006
Patients with cancer are at increased risk of venous thromboembolism (VTE) compared with patients without cancer. This results from both the prothrombotic effects of the cancer itself and iatrogenic factors, such as chemotherapy, radiotherapy, indwelling
Erhard Hiller, Hiller, Erhard
core   +1 more source

Omalizumab as a Provoking Factor for Venous Thromboembolism

open access: yesDrug Target Insights, 2019
A 43-year-old man with a history of severe extrinsic allergic asthma treated with once-monthly omalizumab (600 mg) for the last 15 months. He presented to the emergency room with a 2-week history of right lower limb pain and chest pleuritic pain ...
Crhistian-Mario Oblitas   +4 more
doaj   +1 more source

Direct Oral Anticoagulants for the Treatment of Unusual-Site Venous Thrombosis: An Update

open access: yesPharmaceutics
Direct oral anticoagulants (DOACs) have emerged as the preferred oral anticoagulant therapy for patients with deep vein thrombosis of the lower extremities and pulmonary embolism. DOACs offer several advantages over vitamin K antagonists, including fixed
Anabel Franco-Moreno   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy